Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Alere Inc    ALR

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets

Alere Inc : Alere Inc. Schedules Conference Call for 8:30 a.m. ET February 8, 2012 to Discuss Fourth Quarter 2011 Results

share with twitter share with LinkedIn share with facebook
share via e-mail
02/01/2012 | 09:20pm CEST

WALTHAM, Mass., Feb. 1, 2012 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced that it will release its fourth quarter 2011 earnings on Wednesday, February 8, 2012. The Company will also host a conference call beginning at 8:30 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call, the Company will discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.

The conference call may be accessed by dialing (800) 860-2442 (domestic) or (412) 858-4600 (international) and asking for Alere Inc. A webcast of the call can also be accessed via the Alere website at www.alere.com/investors, or directly through the following link: http://www.videonewswire.com/event.

A replay will be available approximately four hours after the conclusion of the call and will remain available for a period of seven days following the call. The replay may be accessed by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international) and entering replay code 10009812. The replay will also be available via online webcast at http://www.videonewswire.com/event or via the Alere website at www.alere.com/investors for a period of 60 days following the call.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, toxicology and women's health. Alere is headquartered in Waltham, Massachusetts.

For additional information on Alere, please visit www.alere.com.

SOURCE Alere Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ALERE INC
09/19 ALERE INC. : Entry into a Material Definitive Agreement, Financial Statements an..
09/19 ALERE : Announces Intent to Voluntarily Delist Series B Convertible Perpetual Pr..
09/19 ALERE INC. : Declares Cash Dividend on its Series B Convertible Perpetual Prefer..
09/16 ALERE INVESTIGATION INITIATED BY FOR : Kahn Swick & Foti, LLC Investigates the O..
09/09 ALERE INVESTIGATION INITIATED BY FOR : Kahn Swick & Foti, LLC Investigates the O..
09/08 ALERE : N.a.s Receives $50000 From Alere-Oafla Grant Program
09/02 ALERE INVESTIGATION INITIATED BY FOR : Kahn Swick & Foti, LLC Investigates the O..
08/18 ABBOTT LABORATORIES : Announces extension of cash tender offer for all outstandi..
08/11 ALERE : Provides Notice to Holders of Series B Convertible Perpetual Preferred S..
08/10 ALERE : Immunalysis Receives FDA Clearance for SEFRIA Fentanyl Urine Drug Screen..
More news
News from SeekingAlpha
09/18 Quidel (QDEL) Updates On Acquisition Of Alere's Assets - Slideshow
09/18 Quidel to take over commercialization of Alere's BNP assays performed on Beck..
08/16 Tracking David Einhorn's Portfolio - Q2 2017 Update
08/15 Top Merger Stocks Held By Fund Managers (Mid Q3-2017)
08/14 New positions at Sandell Asset Management